Radiology, Mayo Clinic, Rochester, Minnesota, USA
Neurosurgery, Mayo Clinic Rochester, Rochester, Minnesota, USA.
J Neurointerv Surg. 2021 Jul;13(7):594-598. doi: 10.1136/neurintsurg-2020-017167. Epub 2021 Mar 15.
We retrospectively evaluated the composition of retrieved clots from ischemic stroke patients to study the association between histological composition and stroke etiology METHODS: Consecutive patients enrolled in the Stroke Thromboembolism Registry of Imaging and Pathology (STRIP) were included in this study. All patients underwent mechanical thrombectomy and retrieved clots were sent to a central core lab for processing. Histological analysis was performed using martius scarlet blue (MSB) staining, and quantification for red blood cells (RBCs), white blood cells (WBCs), fibrin and platelets was performed using Orbit Image Software. A Wilcoxon test was used for continuous variables and χ test for categorical variables.
1350 patients were included in this study. The overall rate of Thrombolysis In Cerebral Infarction (TICI) 2c/3 was 68%. 501 patients received tissue plasminogen activator (tPA) (37%). 267 patients (20%) had a large artery atherosclerosis (LAA) source, 662 (49%) a cardioembolic (CE) source, 301 (22%) were cryptogenic, and the remainder had other identifiable sources including hypercoagulable state or dissection. LAA thrombi had a higher mean RBC density (46±23% vs 42±22%, p=0.01) and a lower platelet density (24±18% vs 27±18%, p=0.03) than CE thrombi. Clots from dissection patients had the highest mean RBC density (50±24%) while clots from patients with a hypercoagulable state had the lowest mean RBC density (26±21%).
Our study found statistically significant but clinically insignificant differences between clots of CE and LAA etiologies. Future studies should emphasize molecular, proteomic and immunohistochemical characteristics to determine links between clot composition and etiology.
我们回顾性评估了缺血性脑卒中患者取栓后血栓的成分,以研究组织学成分与卒中病因之间的关系。
本研究纳入了连续入组Stroke Thromboembolism Registry of Imaging and Pathology(STRIP)的患者。所有患者均接受机械取栓治疗,并将取栓后血栓送至中心核心实验室进行处理。采用马休猩红蓝(MSB)染色进行组织学分析,并使用 Orbit Image 软件对红细胞(RBCs)、白细胞(WBCs)、纤维蛋白和血小板进行定量分析。采用 Wilcoxon 检验进行连续变量分析,采用卡方检验进行分类变量分析。
本研究共纳入 1350 例患者。总体 TICI 2c/3 再通率为 68%。501 例患者接受了组织型纤溶酶原激活剂(tPA)治疗(37%)。267 例(20%)患者存在大动脉粥样硬化(LAA)来源,662 例(49%)患者存在心源性栓塞(CE)来源,301 例(22%)患者为隐源性,其余患者存在其他可识别的病因,包括高凝状态或夹层。LAA 血栓的 RBC 密度平均值(46±23%)高于 CE 血栓(42±22%)(p=0.01),血小板密度平均值(24±18%)低于 CE 血栓(27±18%)(p=0.03)。夹层患者的血栓 RBC 密度平均值最高(50±24%),高凝状态患者的血栓 RBC 密度平均值最低(26±21%)。
本研究发现 CE 与 LAA 病因的血栓之间存在统计学显著但临床意义不大的差异。未来的研究应强调分子、蛋白质组学和免疫组织化学特征,以确定血栓成分与病因之间的联系。